share_log

1933 Industries Reports Second Quarter 2023 Financial Results and Announces Ester Vigil as President

1933 Industries Reports Second Quarter 2023 Financial Results and Announces Ester Vigil as President

1933 年工業報告 2023 年第二季度財務業績並宣佈 Eester 守夜總裁
Accesswire ·  2023/04/03 20:45

VANCOUVER, BC / ACCESSWIRE / April 3, 2023 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCQB:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce its second quarter financial results ("Q2 2023") For the six months ended January 31, 2023, and 2022. All amounts expressed are in Canadian dollars.

不列顛哥倫比亞省溫哥華/ACCESSWIRE/2023年4月3日/1933工業公司(以下簡稱“公司”或“1933工業公司”)(CSE:TGIF)(場外交易市場代碼:TGIFF)是一家專注於內華達州的大麻種植和生產商,該公司高興地宣佈了截至2023年1月31日和2022年1月31日的六個月的第二季度財務業績(“2023年第二季度”)。所有金額均以加元表示。

The Company owns 91% of Alternative Medicine Association (AMA), the Company's cultivation and production subsidiary focused on the medical and adult-use cannabis market, and 100% of CBD product manufacturer Infused MFG LLC (Infused). The Company's revenue is derived from wholesale cannabis sales in Nevada (AMA), and from the sale of hemp-derived consumer packaged goods (Infused) under the Canna Hemp brand sold across the US via e-commerce at cannahemp.com.

該公司擁有替代醫學協會(AMA)91%的股份,AMA是公司專注於醫用和成人用大麻市場的種植和生產子公司,以及CBD產品製造商Infed MFG LLC的100%股份。該公司的收入來自內華達州(AMA)的大麻批發銷售,以及美人掌大麻下大麻衍生消費包裝商品(注入)的銷售該品牌通過canahemp.com上的電子商務在美國各地銷售。

Q1 2023 Financial Highlights

2023年第一季度財務亮點

  • Revenue $3.6 million for Q2 2023 and $9.2 million for the six months ended January 31, 2023
  • Expenses $0.2 million
  • Gross margin $1.9 million before adjustments
  • Net loss $0.4 million
  • Adjusted EBITDA $0.1 million - Second consecutive quarter of positive EBITDA
  • 2023年第二季度收入360萬美元,截至2023年1月31日的6個月收入920萬美元
  • 支出20萬美元
  • 調整前毛利率為190萬美元
  • 淨虧損40萬美元
  • 調整後的EBITDA為10萬美元-連續第二個季度EBITDA為正

Consolidated Operating Highlights

綜合運營亮點

  • Total revenues were $3.6 million for Q2 2023, representing a 13% increase over $3.2 million for Q2 2022. Revenues are $9.2 million for the six months ended January 31, 2023, representing a 52% increase from $6.0 million during the same period in 2022.
  • Expenses of $0.2 million for Q2 2023 decreased by 92% from $2.4 million in Q2 2022 in large part due to a substantial tax refund from the IRS. The Company continues to work diligently on controlling expenses.
  • Gross margin was $1.9 million, before fair value adjustments on biological assets and realized fair value adjustments on the sale of inventory. The decrease in gross margin is attributable to a decrease in flower pricing in Nevada.
  • Net loss was $0.4 million for Q2 2023 and $0.8 million for Q2 2022.
  • Adjusted EBITDA was $0.1 million for Q2 2023 and $0.1 million for Q2 2022.
  • Cash at the end of the period was $2.9 million compared to $0.8 million during the same period in 2022.
  • 2023年第二季度總收入為360萬美元,比2022年第二季度的320萬美元增長13%。截至2023年1月31日的6個月,收入為920萬美元,比2022年同期的600萬美元增長了52%。
  • 2023年第二季度的支出為20萬美元,較2022年第二季度的240萬美元下降了92%,這在很大程度上是由於美國國稅局的大量退稅。公司將繼續努力控制開支。
  • 在生物資產公允價值調整和出售存貨實現公允價值調整之前,毛利率為190萬美元。毛利率的下降歸因於內華達州鮮花價格的下降。
  • 2023年第二季度淨虧損40萬美元,2022年第二季度淨虧損80萬美元。
  • 2023年第二季度調整後的EBITDA為10萬美元,2022年第二季度為10萬美元。
  • 期末現金為290萬美元,而2022年同期為80萬美元。

Management Commentary

管理評論

Mr. Paul Rosen, Chairman and CEO of 1933 Industries commented, "Wholesale pricing pressure continues to impact cultivators in Nevada, with lower sale prices on cannabis products experienced across the industry. In addition, the Company has chosen to deal with some legacy infrastructure issues that compressed our overall capacity this quarter. During the reporting period, the Company continued to focus on strengthening its operation. Necessary and essential infrastructure improvements to the Company's cultivation facility, including improvements to the facility's irrigation, air movement and humidification systems have been initialized and are well underway. A build-up of inventory will be the Company's priorities in the following quarters in order to increase the production of sellable dried flower and pre-rolls. We expect flower prices to stabilize in the near future, and we expect as well that the launch of consumption lounges will create a new attraction for visitors to the state and expand cannabis-related tourism. The Company is well positioned to benefit from increased demand, flower price stabilization, and the strength of its top brand and in-demand products that deliver excellent value to consumers.

1933工業公司董事長兼首席執行官保羅·羅森先生評論說:“批發價格壓力繼續影響著內華達州的種植者,整個行業的大麻產品銷售價格都較低。此外,該公司選擇處理一些遺留的基礎設施問題,這些問題壓縮了我們本季度的整體產能。在本報告所述期間,公司繼續專注於加強運營。對公司種植設施的必要和必要的基礎設施改進,包括對設施的灌溉、空氣流動和加濕系統的改進已經啟動並正在順利進行。增加庫存將是該公司在接下來幾個季度的優先事項,以增加可銷售的乾花和預捲的產量。我們預計鮮花價格將在不久的將來穩定下來,我們還預計消費休息室的推出將為該州的遊客創造一個新的吸引力,並擴大與大麻相關的旅遊業。該公司處於有利地位,受益於需求的增加、花卉價格的穩定以及其頂級品牌和需求旺盛的產品的實力,這些產品為消費者帶來了極好的價值。

Operationally, the Company has made substantial improvements in lowering its debt load, reducing expenses, and conserving its working capital over the last several quarters. The Company recorded positive Adjusted EBITDA for a second quarter in a row, a milestone in the Company's history."

在運營方面,該公司在過去幾個季度在降低債務負擔、減少開支和節省營運資本方面取得了重大改進。公司連續第二個季度錄得調整後EBITDA為正數,這是公司歷史上的一個里程碑。“

Appointment of Ester Vigil as President

任命維吉爾為總裁

The Company is pleased to announce that Ms. Ester Vigil has been appointed as President. Ms. Vigil previously held the role of Director of Sales and served as president from 2019 to 2020. Ms. Vigil's return to the Company has been marked by significant achievements, including repositioning AMA as a top brand in Nevada. "Ester's contributions to the Company are very meaningful," said Mr. Rosen. "She has added value in all areas of our business, and her leadership has earned her esteem and respect from both her colleagues at 1933, and throughout the overall Nevada cannabis industry. I look forward to Ester continuing to help improve our business, deliver excellent value to our customers and deliver future growth."

本公司高興地宣佈,Ester Vigil女士已被任命為總裁。維吉爾女士此前擔任董事銷售部職務,並於2019年至2020年擔任總裁。Vigil女士重返公司取得了重大成就,包括將AMA重新定位為內華達州的頂級品牌。羅森先生說:“埃斯特公司對公司的貢獻非常有意義。她在我們業務的所有領域都增加了價值,她的領導能力贏得了她在1933年的同事以及整個內華達州大麻行業的尊重和尊重。我期待埃斯特繼續幫助改善我們的業務,為我們的客戶提供卓越的價值,並實現未來的增長。

Financial statements are prepared in accordance with International Financial Reporting Standards. Detailed information regarding the Company's financial results as well as management's discussion and analysis can be found at and

財務報表是根據國際財務報告準則編制的。有關公司財務業績以及管理層的討論和分析的詳細資訊,請訪問和

Please note the next financial release dates in accordance with the continuous disclosure schedule set out by the British Columbia Securities Commission:

請注意,根據不列顛哥倫比亞省證券委員會制定的持續披露時間表,下一次財務發佈日期:

2023 Financial Release Dates

Reporting Quarter Release Date
Q3/2023 June 29, 2023
Q4/YE 2023 November 28, 2023
Q1/2024 January 1, 2024
Q2/2024 April 2, 2024
Q3/2024 July 2, 2024
Q4/YE 2024 November 28, 2024

2023年財務發佈日期

報告季度 發佈日期
2023年第三季度 2023年6月29日
2023年第4季度 2023年11月28日
2024年第一季度 2024年1月1日
2024年第二季度 2024年4月2日
2024年第三季度 2024年7月2日
2024年第4季度 2024年11月28日

About 1933 Industries Inc.

關於1933工業公司

1933 Industries is a Nevada-based, growth-orientated company, focusing on the cultivation and manufacturing of a large portfolio of cannabis consumer-packaged goods in a variety of formats for both the wholesale and retail markets. Its product offerings include: THC flower, pre-rolls, and extracted products under the AMA and Level X brands for the Nevada market; Canna Hemp, national cannabidiol (CBD) brand of infused wellness products including tinctures, gummies, topicals and sport recovery products. The Company owns 91% of Alternative Medicine Association, LC (AMA) and 100% of Infused MFG LLC (Infused).

1933 Industries是一家總部位於內華達州、以增長為導向的公司,專注於為批發和零售市場種植和製造各種形式的大麻消費品組合。該公司提供的產品包括:面向內華達州市場的AMA和Level X品牌的THC鮮花、預捲和提取產品;美人掌、國家大麻二醇(CBD)品牌的灌注型保健產品,包括藥酒、口香糖、外用藥品和運動康復產品。該公司擁有替代醫學協會LC(AMA)91%的股份和INFINED MFG LLC(INFUSED)100%的股份。

About Alternative Medicine Association

關於替代醫學協會

AMA is a licensed medical and adult-use cannabis cultivation and extraction subsidiary that produces its own branded line of unique cannabis products. AMA's extensive menu of cannabis products include: craft cannabis flower, pre-rolls, full spectrum oils, high quality distillates, proprietary blends of terpenes, vaporizer products and boutique concentrates such as shatter, crumble, batter, sugar wax, diamonds, and live resin. Ultra-craft brand Level X is an exclusive collection of exotic strains, selected specifically for their distinctive terpene profiles, high THC levels, and flavonoids. With state-of-the-art cultivation and extraction facilities based in Las Vegas, Nevada, AMA seeks to offer medical patients and recreational users alike a cannabis experience that's exceptional, potent, and consistent in quality.

AMA是一家獲得許可的醫療和成人用大麻種植和提取子公司,生產自己的獨特大麻產品品牌系列。AMA的大麻產品種類繁多,包括:工藝大麻花、預捲、全光譜油、高品質餾分、專有的萜烯混合物、蒸發產品和精品濃縮物,如碎、碎、麵糊、糖蠟、鑽石和活樹脂。超級工藝品牌Level X是外來菌株的獨家收藏,特別是因為它們獨特的萜類特徵、高THC水準和黃酮類化合物而被挑選出來。憑藉位於內華達州拉斯維加斯的最先進的種植和提取設施,AMA尋求為醫療患者和娛樂用戶提供非凡、有效和質量一致的大麻體驗。

AMA is also licensed in Nevada as an adult-use cannabis distributor.

AMA還在內華達州獲得了成人用大麻經銷商的許可。

About Canna Hemp

關於美人掌大麻

With over 60 products in its portfolio, the Canna Hemp brand offers products in a variety of verticals and consumption formats, including, effects-based tinctures, topicals, vape pens and cartridges, gummies, and capsules for Sleep, Relief, Calm, Focus and Energy. High-grade CBD and a proprietary blend of terpenes formulated for specific effects are key differentiators for the Canna Hemp line. The Company recently introduced previously untapped cannabinoids Cannabigerol (CBG) and Cannabinol (CBN) to its portfolio of products with a new line of natural tinctures and gummies.

美人掌大麻品牌在其產品組合中擁有60多種產品,提供各種垂直和消費形式的產品,包括基於效果的酊劑、外用藥物、蒸汽筆和彈藥筒、口香糖和睡眠、舒緩、鎮靜、專注和能量膠囊。高級CBD和為特定效果而配製的專有萜烯混合物是美人掌大麻系列的關鍵區別。該公司最近在其產品組合中引入了以前未開發的大麻酚(CBG)和大麻酚(CBN),並推出了一系列新的天然酊劑和膠水。

For further information please contact:
Alexia Helgason, VP, IR, Marketing, Media
604-728-4407

欲瞭解更多資訊,請聯繫:
阿列克西亞·赫爾加森,媒體市場營銷副總裁
604-728-4407

alexia@1933industries.com
Paul Rosen, CEO
paul@1933industries.com

郵箱:alexia@1933Industrial es.com
保羅·羅森,首席執行官
郵箱:Paul@1933Industrial es.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

加拿大證券交易所及其監管服務提供商(該術語在加拿大證券交易所的政策中定義)均不對本新聞稿的充分性或準確性承擔責任。

Notice regarding Forward Looking Statements: This news release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents, which can be found under the Company's profile on . 1933 Industries undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

有關前瞻性陳述的通知:本新聞稿包含前瞻性陳述。使用“預期”、“繼續”、“估計”、“預期”、“可能”、“將”、“專案”、“應該”、“相信”和類似詞語中的任何一個都是為了識別前瞻性陳述。儘管公司認為前瞻性陳述所基於的預期和假設是合理的,但不應過度依賴前瞻性陳述,因為公司不能保證它們將被證明是正確的。由於前瞻性陳述涉及未來的事件和情況,它們本身就具有內在的風險和不確定性。這些陳述僅代表本新聞稿發佈之日的情況。由於許多因素和風險,包括公司披露檔案中討論的各種風險因素,實際結果可能與目前預期的大不相同,這些因素和風險可以在公司簡介中找到。除非法律要求,否則工業公司不承擔公開更新或修改任何前瞻性資訊的義務,無論是由於新資訊、未來事件還是其他原因。

SOURCE: 1933 Industries Inc.

資料來源:1933年工業公司


View source version on accesswire.com:
在accesswire.com上查看源代碼版本:

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論